<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03516578</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT03516578</nct_id>
  </id_info>
  <brief_title>CMR for Prognosis Assessment in NSTEMI</brief_title>
  <official_title>Comprehensive Cardiac Magnetic Resonance Imaging For Prognosis Assessment After Non-ST-Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heartcenter Leipzig GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heartcenter Leipzig GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prognostic significance of cardiac magnetic resonance (CMR) derived parameters of
      myocardial and microvascular injury has not been fully elucidated yet in non-ST-Elevation
      myocardial infarction (NSTEMI) patients. In the present study the investigators aim to
      comprehensively investigate the prognostic significance of CMR in a prospective, multicentre
      registry cohort of NSTEMI patients undergoing early percutaneous coronary intervention (PCI).
      CMR will be performed within the first week following the index event. The primary endpoint
      is defined as a composite of death, reinfarction, and new congestive heart failure (major
      adverse cardiac events) at 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2011</start_date>
  <completion_date type="Actual">March 28, 2018</completion_date>
  <primary_completion_date type="Actual">March 28, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of death, reinfarction and new congestive heart failure</description>
  </primary_outcome>
  <enrollment type="Actual">314</enrollment>
  <condition>Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac magnetic resonance imaging</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the chest pain units of three primary care clinics are screened for
        study participation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients are eligible for the study if they have: 1) ischemic symptoms
        in accordance with a possible NSTEMI diagnosis; 2) elevated cardiac troponin levels above
        the 99th percentile; and 3) identifiable culprit lesion during early invasive coronary
        angiography with performed PCI.

        Exclusion Criteria: 1) STEMI; 2) presence of cardiogenic shock; 3) no identifiable culprit
        lesion or culprit lesion ineligible for PCI; 4) indication for acute bypass surgery; 5) age
        less than 18 years or more than 90 years; 6) pregnancy; and 7) typical contraindications to
        CMR (e.g. severe claustrophobia, implanted pacemakers and internal cardioverter
        defibrillators, cerebral or intracranial metallic implants, known allergy to gadolinium and
        creatinine clearance &lt;30 mL/min).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non-ST-elevation myocardial infarction</keyword>
  <keyword>cardiac magnetic resonance</keyword>
  <keyword>prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

